Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
41
EXAS Quote, Financials, Valuation and Earnings
Last price:
$58.94
Seasonality move
:
15.47%
Day range:
$55.98 - $59.70
52-week range:
$40.62 - $79.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.04x
P/B ratio:
3.42x
Volume:
2.9M
Avg. volume:
2.7M
1-year change:
-11.8%
Market cap:
$11B
Revenue:
$2.5B
EPS (TTM):
-$1.17
Earnings Data
Next earnings date for EXAS
Feb 21
2025
Most recent earnings per share
-$0.21
Missed by $0.11
(Nov 5/2024)
Consensus Estimate
-$0.10
(Nov 5/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EXAS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/21/2025 | Q4 | $694.7M | -- | -- | -$0.22 | -- |
| 11/05/2024 | Q3 | $717M | $708.7M | -$0.21 | -$0.10 | -$0.11 |
| 07/31/2024 | Q2 | $690.1M | $699.3M | -$0.09 | -$0.24 | $0.15 |
| 05/08/2024 | Q1 | $626.8M | $637.5M | -$0.60 | -$0.41 | -$0.19 |
| 02/21/2024 | Q4 | $639.7M | $646.9M | -$0.27 | -$0.36 | $0.09 |
| 11/01/2023 | Q3 | -- | -- | $0.00 | -$0.43 | $0.44 |
| 08/01/2023 | Q2 | -- | -- | -$0.45 | -$0.41 | -$0.04 |
| 05/09/2023 | Q1 | -- | -- | -$0.42 | -$0.66 | $0.24 |
| 02/21/2023 | Q4 | -- | -- | -$0.72 | -$0.78 | $0.06 |
| 11/03/2022 | Q3 | -- | -- | -$0.84 | -$1.05 | $0.21 |
| 08/02/2022 | Q2 | -- | -- | -$0.94 | -$1.04 | $0.10 |
| 04/26/2022 | Q1 | -- | -- | -$1.04 | -$1.04 | -- |
| 02/22/2022 | Q4 | -- | -- | -$1.28 | -$0.88 | -$0.40 |
| 11/02/2021 | Q3 | -- | -- | -$0.97 | -$0.83 | -$0.14 |
| 07/28/2021 | Q2 | -- | -- | -$1.03 | -$0.72 | -$0.31 |
| 05/04/2021 | Q1 | -- | -- | -$0.18 | -$0.94 | $0.76 |
| 02/16/2021 | Q4 | -- | -- | -$2.79 | -$0.26 | -$2.53 |
| 10/29/2020 | Q3 | -- | -- | -$1.46 | -$0.57 | -$0.89 |
| 07/30/2020 | Q2 | -- | -- | -$0.58 | -$0.65 | $0.07 |
| 05/06/2020 | Q1 | -- | -- | -$0.71 | -$0.52 | -$0.19 |
| 02/11/2020 | Q4 | -- | -- | $0.54 | -$0.36 | $0.90 |
| 10/29/2019 | Q3 | -- | -- | -$0.31 | -$0.41 | $0.10 |
| 07/30/2019 | Q2 | -- | -- | -$0.30 | -$0.56 | $0.26 |
| 04/30/2019 | Q1 | -- | -- | -$0.66 | -$0.65 | -$0.01 |
| 02/21/2019 | Q4 | -- | -- | -$0.44 | -$0.48 | $0.04 |
| 10/30/2018 | Q3 | -- | -- | -$0.37 | -$0.43 | $0.06 |
| 08/01/2018 | Q2 | -- | -- | -$0.30 | -$0.33 | $0.03 |
| 04/26/2018 | Q1 | -- | -- | -$0.33 | -$0.38 | $0.05 |
| 02/22/2018 | Q4 | -- | -- | -$0.18 | -$0.24 | $0.06 |
| 10/31/2017 | Q3 | -- | -- | -$0.23 | -$0.30 | $0.07 |
| 07/25/2017 | Q2 | -- | -- | -$0.27 | -$0.35 | $0.08 |
| 04/27/2017 | Q1 | -- | -- | -$0.32 | -$0.41 | $0.09 |
| 02/21/2017 | Q4 | -- | -- | -$0.34 | -$0.40 | $0.06 |
| 10/26/2016 | Q3 | -- | -- | -- | -- | -- |
| 07/26/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/03/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/24/2016 | Q4 | -- | -- | -- | -- | -- |
| 10/29/2015 | Q3 | -- | -- | -- | -- | -- |
| 07/20/2015 | Q2 | -- | -- | -- | -- | -- |
| 05/04/2015 | Q1 | -- | -- | -- | -- | -- |
| 02/24/2015 | Q4 | -- | -- | -- | -- | -- |
Exact Sciences Earnings Questions
-
How Much did Exact Sciences Generate in Revenue Last Quarter?
Exact Sciences reported $708.7M worth of top line sales in its most recent quarter.
-
Did Exact Sciences Beat Earnings Last Quarter?
Exact Sciences announced earnings per share of -$0.21 which represents a miss of analyst forecast a -$0.10 per share.
-
Is Exact Sciences Profitable?
Exact Sciences reported $512.6M that represents $2.77 per share over the last quarter.
-
What is the Analyst Consensus for Exact Sciences EPS Next Year?
Exact Sciences's earnings are forecast to decrease from -$1.13 per share to -$1.15 per share next year representing a decrease of -50.2%.
-
When is Exact Sciences's Earnings Date?
Exact Sciences's next earnings date is February 21, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 0.51% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 7.38% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.32% over the past day.
